(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RITEDOSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RITEDOSE

ST13

US500000097124132

Class

5, 40

Filing

97124132

Registration

7305546

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

01/02/2025

Trademark type

Word

Nice classes

5, 40

Filing date

11/14/2021

Registration date

02/13/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/13/2024

Last transaction

01/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/01/2011

First use in commerce

07/01/2011

Drawing code

4

Owner type

03

Owner location

COLUMBIA, SC

Examiner

SPARACINO, MARK

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

T. C. (pessoa física)

Representatives

The Ritedose Corporation

Technical classification

Nice Classes

Class 5Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical oral liquid preparations for the treatment of coldsallergiescoughssinus ailmentsfeversgastrointestinal ailmentsdigestive ailmentscardiovascular ailmentscirculatory ailmentsblood anomaliesrespiratory ailmentsmuscular-skeletal disorderseye disordersoral-ear-nose and throat problemsparasitic problemsendocrine problemsmale and female sexual performance problemsreproductive system problemsurologic and urinary tract problemshormone deficienciesskin disordersinfectionsneurological problemsinsomniahair lossimmunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of coldsallergiescoughssinus ailmentsfeversgastrointestinal ailmentsdigestive ailmentscardiovascular ailmentscirculatory ailmentsblood anomaliesrespiratory ailmentsmuscular-skeletal disorderseye disordersoral-ear-nose and throat problemsparasitic problemsendocrine problemsmale and female sexual performance problemsreproductive system problemsurologic and urinary tract problemshormone deficienciesskin disordersinfectionsneurological problemsinsomniahair lossimmunologic ailments

Class 40

Custom manufacture of pharmaceuticals to the order and specification of others. Repackaging services for others in the field of pharmaceuticals and other preparations for medical or veterinary purposes; Providing contract development and manufacturing organization (CDMO) servicesby providing contract manufacturing of pharmaceuticals for specific companies

Publications

History of USPTO decisions and trademark events.

53 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/01/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/13/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/13/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/09/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/08/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

01/08/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/08/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

01/08/2024

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

01/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/12/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/11/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/11/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/01/2023

GNRT

NON-FINAL ACTION E-MAILED

12/01/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

12/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/05/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/05/2023

ALIE

ASSIGNED TO LIE

11/05/2023

NREV

NOTICE OF REVIVAL - E-MAILED

11/02/2023

PGRR

PETITION GRANTED - RESPONSE RECEIVED

11/02/2023

APET

ASSIGNED TO PETITION STAFF

10/30/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/14/2023

PROA

TEAS PETITION TO REVIVE RECEIVED

09/14/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/08/2023

GNRT

NON-FINAL ACTION E-MAILED

06/08/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

06/08/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/10/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/09/2023

EX1G

SOU EXTENSION 1 GRANTED

05/09/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/08/2023

IUAF

USE AMENDMENT FILED

04/18/2023

EISU

TEAS STATEMENT OF USE RECEIVED

04/18/2023

NREV

NOTICE OF REVIVAL - E-MAILED

04/18/2023

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

04/18/2023

PETG

PETITION TO REVIVE-GRANTED

04/18/2023

PROA

TEAS PETITION TO REVIVE RECEIVED

04/18/2023

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

04/10/2023

ABN6

ABANDONMENT - NO USE STATEMENT FILED

04/10/2023

EXT1

SOU EXTENSION 1 FILED

03/06/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/06/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/12/2022

PUBO

PUBLISHED FOR OPPOSITION

07/12/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/22/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/03/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/24/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/23/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/23/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/13/2022

GNRT

NON-FINAL ACTION E-MAILED

04/13/2022

CNRT

NON-FINAL ACTION WRITTEN

04/13/2022

DOCK

ASSIGNED TO EXAMINER

04/11/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/19/2021

NWAP

NEW APPLICATION ENTERED

11/17/2021

Continuous trademark protection

Get notified about every new filing that threatens RITEDOSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.